145 related articles for article (PubMed ID: 28294049)
1. In silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.
Ghaffar A; Batool S; Mushtaq G; Kamal MA
Curr Comput Aided Drug Des; 2017; 13(3):222-233. PubMed ID: 28294049
[TBL] [Abstract][Full Text] [Related]
2. Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach.
Huang T; Sun J; Zhou S; Gao J; Liu Y
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665353
[TBL] [Abstract][Full Text] [Related]
3. Discovery of natural adenosine monophosphate‑activated protein kinase activators through virtual screening and activity verification studies.
Hao J; Yang Z; Li J; Han L; Zhang Y; Wang T
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495803
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential AMPK activator by pharmacophore modeling, molecular docking and QSAR study.
Li Y; Peng J; Li P; Du H; Li Y; Liu X; Zhang L; Wang LL; Zuo Z
Comput Biol Chem; 2019 Apr; 79():165-176. PubMed ID: 30836318
[TBL] [Abstract][Full Text] [Related]
5. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities.
Vazirian M; Nabavi SM; Jafari S; Manayi A
Food Chem Toxicol; 2018 Dec; 122():69-79. PubMed ID: 30290216
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators.
Cameron KO; Kurumbail RG
Bioorg Med Chem Lett; 2016 Nov; 26(21):5139-5148. PubMed ID: 27727125
[TBL] [Abstract][Full Text] [Related]
7. Targeting of AMP-activated protein kinase: prospects for computer-aided drug design.
Kim J; Yang G; Ha J
Expert Opin Drug Discov; 2017 Jan; 12(1):47-59. PubMed ID: 27797589
[TBL] [Abstract][Full Text] [Related]
8. Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators.
Dokla EM; Fang CS; Lai PT; Kulp SK; Serya RA; Ismail NS; Abouzid KA; Chen CS
ChemMedChem; 2015 Nov; 10(11):1915-23. PubMed ID: 26350292
[TBL] [Abstract][Full Text] [Related]
9. Biophysical Interactions of Direct AMPK Activators.
Kurumbail RG; West GM; Dharmarajan V; Borzilleri KA; Withka JM; Ward J; Reyes AR; Rajamohan F; Griffin PR; Calabrese MF
Methods Mol Biol; 2018; 1732():29-55. PubMed ID: 29480467
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided drug design for AMP-activated protein kinase activators.
Wang Z; Huo J; Sun L; Wang Y; Jin H; Yu H; Zhang L; Zhou L
Curr Comput Aided Drug Des; 2011 Sep; 7(3):214-27. PubMed ID: 21595631
[TBL] [Abstract][Full Text] [Related]
11. Repurposing existing drugs for new AMPK activators as a strategy to extend lifespan: a computer-aided drug discovery study.
Mofidifar S; Sohraby F; Bagheri M; Aryapour H
Biogerontology; 2018 Apr; 19(2):133-143. PubMed ID: 29335817
[TBL] [Abstract][Full Text] [Related]
12. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.
Arkwright RT; Deshmukh R; Adapa N; Stevens R; Zonder E; Zhang Z; Farshi P; Ahmed RS; El-Banna HA; Chan TH; Dou QP
Anticancer Agents Med Chem; 2015; 15(5):657-71. PubMed ID: 25511514
[TBL] [Abstract][Full Text] [Related]
13. Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a Diverse Therapeutic Target: A Computational Perspective.
Ramesh M; Vepuri SB; Oosthuizen F; Soliman ME
Appl Biochem Biotechnol; 2016 Feb; 178(4):810-30. PubMed ID: 26541160
[TBL] [Abstract][Full Text] [Related]
14. Ligand and structure-based approaches for the identification of SIRT1 activators.
Vyas VK; Goel A; Ghate M; Patel P
Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-containing pyrazolo[3,4-b]pyridinones as a new series of AMPKɑ1β1γ1 activators.
Xiao Z; Peng Y; Zheng B; Chang Q; Guo Y; Chen Z; Li Q; Hu G
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000458. PubMed ID: 33683726
[TBL] [Abstract][Full Text] [Related]
16. Activating Effect of 3-Benzylidene Oxindoles on AMPK: From Computer Simulation to High-Content Screening.
Novikova DS; Grigoreva TA; Ivanov GS; Melino G; Barlev NA; Tribulovich VG
ChemMedChem; 2020 Dec; 15(24):2521-2529. PubMed ID: 32762073
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPKα2β1γ1 activators.
Wang J; Liu J; Xie Z; Li J; Li J; Hu L
Bioorg Med Chem Lett; 2020 Jan; 30(2):126790. PubMed ID: 31744674
[TBL] [Abstract][Full Text] [Related]
18. Development of novel adenosine monophosphate-activated protein kinase activators.
Guh JH; Chang WL; Yang J; Lee SL; Wei S; Wang D; Kulp SK; Chen CS
J Med Chem; 2010 Mar; 53(6):2552-61. PubMed ID: 20170185
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design.
Miglianico M; Nicolaes GA; Neumann D
J Med Chem; 2016 Apr; 59(7):2879-93. PubMed ID: 26510622
[TBL] [Abstract][Full Text] [Related]
20. Effective virtual screening strategy focusing on the identification of novel Bruton's tyrosine kinase inhibitors.
Xiao J; Zhang S; Luo M; Zou Y; Zhang Y; Lai Y
J Mol Graph Model; 2015 Jul; 60():142-54. PubMed ID: 26043662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]